Clinical Research Directory
Browse clinical research sites, groups, and studies.
Validating CGM for GDM
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Official title: The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2025-10-02
Completion Date
2028-04
Last Updated
2026-01-15
Healthy Volunteers
Yes
Conditions
Interventions
Continuous glucose monitor
Device is a remote sensor applied to the upper extremity that continuously samples glucose of interstitial fluid and uploading results to a mobile application.
Locations (2)
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Mount Sinai South Nassau
Oceanside, New York, United States